MDWD

MKT CAP:$182M

MediWound Ltd.

Market Cap

$182M

Healthcare·Biotechnology·🇮🇱 Israel·NASDAQ

Healthcare·Biotechnology·🇮🇱·NASDAQ

Stock Price

$16.65-$1.77 (-9.61%)

Apr 23, 2026

Company Details

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a de...

CEO

Ofer Gonen

IPO Date

Mar 20, 2014

Website

www.mediwound.com

Key Metrics TTM

Revenue

$17M

-16.1% YoY

Net Income

-$24M

EPS (Diluted)

-$2.10

Free Cash Flow

-$21M

Revenue / Share

$1.32

Gross Margin

19.2%

Operating Margin

-149.1%

Net Margin

-140.8%

FCF Margin

-122.7%

P/S

10.7x

P/E

—

Earnings Reports

FY 2025

Mar 5, 2026

$17M-16.1%EPS -$2.10

Q4 2025

Mar 5, 2026

$2M-68.0%EPS -$0.56

Q3 2025

Nov 20, 2025

$5M+24.7%EPS -$0.24

Q2 2025

Aug 14, 2025

$6M+12.7%EPS -$1.23

Q1 2025

May 21, 2025

$4M-20.3%EPS -$0.07

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$4M	$1M	-$3M
Q2 22	$5M	$1M	-$3M
Q3 22	$6M	$2M	-$4M
Q4 22	$12M	$8M	$2M
Q1 23	$4M	$826.0K	-$4M
Q2 23	$5M	$1M	-$4M
Q3 23	$5M	$896.0K	-$3M
Q4 23	$5M	$719.0K	-$4M
Q1 24	$5M	$607.0K	-$4M
Q2 24	$5M	$447.0K	-$4M
Q3 24	$4M	$677.0K	-$5M
Q4 24	$6M	$903.0K	-$6M
Q1 25	$4M	$738.0K	-$5M
Q2 25	$6M	$1M	-$6M
Q3 25	$5M	$896.0K	-$7M
Q4 25	$2M	$278.0K	-$8M

Valuation

Quarter	P/S	P/E
Q1 22	8.1x	—
Q2 22	8.7x	—
Q3 22	8.9x	—
Q4 22	6.9x	—
Q1 23	7.0x	—
Q2 23	7.0x	—
Q3 23	7.3x	—
Q4 23	9.7x	—
Q1 24	9.2x	—
Q2 24	9.0x	—
Q3 24	9.2x	—
Q4 24	9.0x	—
Q1 25	9.5x	—
Q2 25	9.2x	—
Q3 25	8.7x	—
Q4 25	10.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$4M	-$4M
Q2 22	-$5M	-$5M
Q3 22	-$5M	-$5M
Q4 22	$2M	$2M
Q1 23	$652.0K	-$853.0K
Q2 23	-$5M	-$6M
Q3 23	-$3M	-$5M
Q4 23	-$2M	-$4M
Q1 24	-$4M	-$5M
Q2 24	-$4M	-$7M
Q3 24	-$4M	-$5M
Q4 24	-$2M	-$2M
Q1 25	-$4M	-$5M
Q2 25	-$6M	-$7M
Q3 25	-$3M	-$4M
Q4 25	-$3M	-$5M

Capital Expenditures

Quarter	CapEx
Q1 22	$160.0K
Q2 22	$138.0K
Q3 22	$83.0K
Q4 22	$174.0K
Q1 23	$2M
Q2 23	$1M
Q3 23	$2M
Q4 23	$2M
Q1 24	$1M
Q2 24	$3M
Q3 24	$1M
Q4 24	$806.0K
Q1 25	$959.0K
Q2 25	$1M
Q3 25	$1M
Q4 25	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	-24.6%	-1.0%
Q2 22	-22.9%	-10.3%
Q3 22	-8.9%	+0.6%
Q4 22	+111.7%	+1.2%
Q1 23	-13.8%	+6.1%
Q2 23	+2.2%	+9.3%
Q3 23	-17.7%	-13.8%
Q4 23	-54.1%	+1.1%
Q1 24	+30.7%	+6.6%
Q2 24	+6.1%	+8.7%
Q3 24	-8.8%	+17.6%
Q4 24	+9.4%	+29.3%
Q1 25	-20.3%	+5.5%
Q2 25	+12.7%	+19.7%
Q3 25	+24.7%	+26.7%
Q4 25	-68.0%	-18.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$345.0K	7.8%
Q2 22	$252.0K	5.4%
Q3 22	$707.0K	12.2%
Q4 22	$642.0K	5.5%
Q1 23	$619.0K	16.3%
Q2 23	$712.0K	14.9%
Q3 23	$311.0K	6.5%
Q4 23	$298.0K	5.6%
Q1 24	$512.0K	10.3%
Q2 24	$758.0K	15.0%
Q3 24	$1M	24.0%
Q4 24	$822.0K	14.1%
Q1 25	$844.0K	21.3%
Q2 25	$862.0K	15.1%
Q3 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 22	$2M	$2M
Q2 22	$2M	$2M
Q3 22	$3M	$3M
Q4 22	$3M	$3M
Q1 23	$2M	$3M
Q2 23	$2M	$3M
Q3 23	$2M	$3M
Q4 23	$2M	$3M
Q1 24	$1M	$3M
Q2 24	$2M	$3M
Q3 24	$3M	$3M
Q4 24	$3M	$4M
Q1 25	$3M	$3M
Q2 25	$3M	$4M
Q3 25	$3M	$4M
Q4 25	$4M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$17M	$0	$17M
Q2 22	$8M	$3M	$10M
Q3 22	$18M	$0	$18M
Q4 22	$34M	$0	$34M
Q1 23	$51M	$6M	$57M
Q2 23	$51M	$0	$51M
Q3 23	$9M	$36M	$46M
Q4 23	$12M	$30M	$42M
Q1 24	$36M	$0	$36M
Q2 24	$4M	$25M	$29M
Q3 24	$6M	$39M	$46M
Q4 24	$9M	$0	$9M
Q1 25	$38M	$0	$38M
Q2 25	$1M	$31M	$32M
Q3 25	$59M	$0	$59M
Q4 25	$5M	$48M	$53M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	4M	+5.4%	+5.5%
Q2 22	5M	+15.3%	+21.6%
Q3 22	5M	+1.0%	+22.9%
Q4 22	6M	+32.4%	+62.7%
Q1 23	8M	+32.4%	+104.3%
Q2 23	9M	+9.8%	+94.5%
Q3 23	9M	+0.1%	+92.7%
Q4 23	9M	+0.0%	+45.6%
Q1 24	9M	+0.2%	+10.1%
Q2 24	9M	+0.5%	+0.8%
Q3 24	11M	+13.3%	+14.0%
Q4 24	11M	+2.7%	+17.0%
Q1 25	11M	+0.1%	+16.9%
Q2 25	11M	+0.3%	+16.8%
Q3 25	11M	+1.7%	+4.9%
Q4 25	13M	+16.4%	+18.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$65.8K	67
Q2 22	$69.7K	67
Q3 22	$86.6K	67
Q4 22	$159.2K	73
Q1 23	$52.0K	73
Q2 23	$65.4K	73
Q3 23	$65.4K	73
Q4 23	$53.4K	100
Q1 24	$49.6K	100
Q2 24	$50.6K	100
Q3 24	$43.5K	100
Q4 24	$52.6K	111
Q1 25	$35.6K	111
Q2 25	$51.4K	111
Q3 25	$48.9K	111
Q4 25	$15.4K	121

Revenue / Employee